73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Tumor mutations may predict response to immunotherapy

Tumor mutations may predict response to immunotherapy

by Johns Hopkins University School of MedicineMismatch repair deficiency refers to a characteristic of some cancer cells that create a large number of mutations, or changes, in certain genes when

Tumor mutations may predict response to immunotherapy

by Johns Hopkins University School of MedicineMismatch repair deficiency refers to a characteristic of some cancer cells that create a large number of mutations, or changes, in certain genes when
Many breast cancer survivors may be able to forgo mammograms in old age

Many breast cancer survivors may be able to forgo mammograms in old age

by Denise MannOlder breast cancer survivors often have other medical issues and a shorter life expectancy than younger breast cancer survivors. What's more, their cancers are often slow-growing, a

Many breast cancer survivors may be able to forgo mammograms in old age

by Denise MannOlder breast cancer survivors often have other medical issues and a shorter life expectancy than younger breast cancer survivors. What's more, their cancers are often slow-growing, a
Study of immune 'neighborhoods' highlights macrophages as key players in invasive breast cancers

Study of immune 'neighborhoods' highlights macrophages as key players in invasive breast cancers

byUniversity of PittsburghCredit: Unsplash/CC0 Public DomainMost immunotherapies, which aim to boost T cell activity, work poorly in treating estrogen receptor-positive (ER+) breast cancer. Targ

Study of immune 'neighborhoods' highlights macrophages as key players in invasive breast cancers

byUniversity of PittsburghCredit: Unsplash/CC0 Public DomainMost immunotherapies, which aim to boost T cell activity, work poorly in treating estrogen receptor-positive (ER+) breast cancer. Targ
Workaround erases side effects of promising cell-based cancer therapy

Workaround erases side effects of promising cell-based cancer therapy

by Bruce Goldman,Stanford University Medical CenterResearch at Stanford are looking at whether a type of immune cell known as a T cell could be taken from a cancer patient, then modified and ret

Workaround erases side effects of promising cell-based cancer therapy

by Bruce Goldman,Stanford University Medical CenterResearch at Stanford are looking at whether a type of immune cell known as a T cell could be taken from a cancer patient, then modified and ret
Targeted therapy better for repeat kidney cancer patients than FDA-approved counterpart

Targeted therapy better for repeat kidney cancer patients than FDA-approved counterpart

by City of HopeKiller T cells surround a cancer cell. Credit: NIHKidney cancer patients who had already tried two or three different treatments had improved chances of preventing cancer progression wi

Targeted therapy better for repeat kidney cancer patients than FDA-approved counterpart

by City of HopeKiller T cells surround a cancer cell. Credit: NIHKidney cancer patients who had already tried two or three different treatments had improved chances of preventing cancer progression wi
One in five GPs unwilling to prescribe aspirin to people at risk of bowel cancer, finds UK study

One in five GPs unwilling to prescribe aspirin to people at risk of bowel cancer, finds UK study

by University of LeedsCredit: Unsplash/CC0 Public DomainOne in five GPs could be unwilling to prescribe aspirin to patients with a cancer-causing syndrome, despite national guidelines advising it

One in five GPs unwilling to prescribe aspirin to people at risk of bowel cancer, finds UK study

by University of LeedsCredit: Unsplash/CC0 Public DomainOne in five GPs could be unwilling to prescribe aspirin to patients with a cancer-causing syndrome, despite national guidelines advising it
COVID-19 pandemic could have led to 20,000 prostate cancer diagnosis being missed

COVID-19 pandemic could have led to 20,000 prostate cancer diagnosis being missed

byUniversity of SurreyObserved and predicted trends over time from January 2015 to July 2023 showing rates per 100 000 registered adult men (A) prostate cancer incidence, (B) prevalence, and (C)

COVID-19 pandemic could have led to 20,000 prostate cancer diagnosis being missed

byUniversity of SurreyObserved and predicted trends over time from January 2015 to July 2023 showing rates per 100 000 registered adult men (A) prostate cancer incidence, (B) prevalence, and (C)
Investigational deep learning model may help stratify risk for patients with endometrial cancer

Investigational deep learning model may help stratify risk for patients with endometrial cancer

by American Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainAn investigational deep learning model requiring one histopathologic slide accurately predicted the risk of distant rec

Investigational deep learning model may help stratify risk for patients with endometrial cancer

by American Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainAn investigational deep learning model requiring one histopathologic slide accurately predicted the risk of distant rec
Engineered receptors help the immune system home in on cancer

Engineered receptors help the immune system home in on cancer

byUniversity of California, San FranciscoCredit: CC0 Public DomainMost cancer treatments—from chemotherapies to engineered immune cells—have a host of side effects, in large part because they af

Engineered receptors help the immune system home in on cancer

byUniversity of California, San FranciscoCredit: CC0 Public DomainMost cancer treatments—from chemotherapies to engineered immune cells—have a host of side effects, in large part because they af
Study: Risk of cancer doubles for people with 'skewed' blood cells

Study: Risk of cancer doubles for people with 'skewed' blood cells

by King's College LondonAge acquired XCI-skew across age groups and time. (A) A histogram displaying the age distribution of the TwinsUK HUMARA cohort (age range: 19–99; median age = 61). (B)

Study: Risk of cancer doubles for people with 'skewed' blood cells

by King's College LondonAge acquired XCI-skew across age groups and time. (A) A histogram displaying the age distribution of the TwinsUK HUMARA cohort (age range: 19–99; median age = 61). (B)
A window into the changing tumor microenvironment

A window into the changing tumor microenvironment

by Ludwig Cancer ResearchGraphical abstract. Credit:iScience(2022). DOI: 10.1016/j.isci.2022.104570Researchers led by Ludwig Lausanne's Anoek Zomer, Davide Croci and Johanna Joyce

A window into the changing tumor microenvironment

by Ludwig Cancer ResearchGraphical abstract. Credit:iScience(2022). DOI: 10.1016/j.isci.2022.104570Researchers led by Ludwig Lausanne's Anoek Zomer, Davide Croci and Johanna Joyce
Researchers identify immune cell that helps kill bladder cancer tumors

Researchers identify immune cell that helps kill bladder cancer tumors

by The Mount Sinai HospitalMyeloid immune cells alongsidered blood cells in an electron micrograph of human blood. Credit: National Cancer InstituteMount Sinai researchers have made two imp

Researchers identify immune cell that helps kill bladder cancer tumors

by The Mount Sinai HospitalMyeloid immune cells alongsidered blood cells in an electron micrograph of human blood. Credit: National Cancer InstituteMount Sinai researchers have made two imp